Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study
Title:
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study
Author:
Lu, Jin Fu, Weijun Li, Wei Hu, Jianda An, Gang Wang, Yafei Fu, Chengcheng Chen, Lijuan Jin, Jie Cen, Xinan Ge, Zheng Cai, Zhen Niu, Ting Qi, Ming Sun, Steven Gai, Xue Liu, Weiping Liu, Wenyu Yang, Xue Huang, Xiaojun